跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,980 条关于
“compensated cirrhosis”
全部
2,980
临床试验
2,600
药物
20
机构
0
资讯
360
2个月前
FDA Grants Premarket Approval to HepQuant SHUNT Liver Diagnostic Test for Compensated Cirrhosis
去年
Akero Therapeutics Doses First Patient in Phase 3 SYNCHRONY Outcomes Trial for MASH Cirrhosis
去年
Akero's Efruxifermin Shows Promise in Reversing Cirrhosis Due to MASH in Phase 2b Trial
去年
Bariatric Surgery Significantly Reduces Liver Complications in Obese Patients with Cirrhosis
2年前
Akero Therapeutics Doses First Patient in Phase 3 SYNCHRONY Outcomes Trial for MASH Cirrhosis
去年
Akero Therapeutics Advances MASH Treatment with Efruxifermin in Phase 3 SYNCHRONY Program
11个月前
Novo Nordisk Acquires Akero Therapeutics for $5.2 Billion to Expand MASH Treatment Portfolio
2个月前
GSK's Efimosfermin Opens Two Phase 3 Trials Targeting MASH Cirrhosis, Signaling a Shift Toward Disease-Modifying Outcomes
去年
Madrigal's Rezdiffra Shows Promise in MASH Cirrhosis with Two-Year Data
2年前
Madrigal's Resmetirom Nears Full Approval for NASH Cirrhosis Treatment Following Phase 3 Enrollment Completion
第 1 页,共 36 页
上一页
下一页